{"id":"W3214742056","doi":"10.1016/j.ctarc.2021.100496","title":"Consolidative durvalumab outcomes in stage III non-small cell lung cancer in a multi-centre study","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Queen's University","funders":"","keywords":"Durvalumab; Medicine; Pneumonitis; Internal medicine; Discontinuation; Lung cancer; Stage (stratigraphy); Clinical endpoint; Hazard ratio; Cancer; Oncology; Radiation therapy; Retrospective cohort study; Gastroenterology; Lung; Immunotherapy; Nivolumab; Clinical trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004149707,0.0001739627,0.0004023633,0.000214868,0.0002469409,0.00004709186,0.000221361,0.0000701808,0.0003336389],"category_scores_gemma":[0.000032403,0.0001362229,0.00007162202,0.0006453337,0.0002541947,0.00006618658,0.0002351672,0.0003784321,0.000003010409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001254438,"about_ca_system_score_gemma":0.001246754,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02604031,"about_ca_topic_score_gemma":0.1337928,"domain_scores_codex":[0.9982476,0.000499086,0.0003218597,0.0003426445,0.0002072011,0.0003816663],"domain_scores_gemma":[0.9982302,0.0003662177,0.00005490608,0.0009841488,0.0002504866,0.0001140205],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004203383,0.005110944,0.96668,0.00006145966,0.0003797739,0.0000699079,0.01800667,0.000008730033,0.002256923,0.00001158098,0.0001202723,0.006873317],"study_design_scores_gemma":[0.0368864,0.0003698554,0.9086703,0.0005321451,0.0001365202,0.000002432457,0.04323518,0.001749812,0.002732277,0.000004309142,0.005428518,0.0002522325],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9472225,0.04423209,0.000002697324,0.005410674,0.00004614174,0.001982868,0.0001198405,0.00001412334,0.00096907],"genre_scores_gemma":[0.9133551,0.07403894,0.0001989145,0.00007180632,0.00001161297,0.001341319,0.00004439779,0.00001888128,0.01091909],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1077525,"threshold_uncertainty_score":0.9804454,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1377422018170724,"score_gpt":0.464566545389948,"score_spread":0.3268243435728756,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}